DK315281A - Fremgangsmaade til fremstilling af pyrimidin-2-oner eller salte deraf - Google Patents

Fremgangsmaade til fremstilling af pyrimidin-2-oner eller salte deraf

Info

Publication number: DK315281A
Authority: DK; Denmark
Prior art keywords: group; compounds; salts; susceptible; phase
Prior art date: 1980-07-15

Application number

DK315281A

Other languages

English (en)

Inventor

G H Phillipps

C Williamson

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-07-15

Filing date

1981-07-15

Publication date

1982-01-16

1981-07-15 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1982-01-16 Publication of DK315281A publication Critical patent/DK315281A/da

Links

238000000034 method Methods 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 abstract 4
230000002159 abnormal effect Effects 0.000 abstract 3
150000003839 salts Chemical class 0.000 abstract 2
125000000041 C6-C10 aryl group Chemical group 0.000 abstract 1
230000002378 acidificating effect Effects 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
230000029936 alkylation Effects 0.000 abstract 1
238000005804 alkylation reaction Methods 0.000 abstract 1
125000003710 aryl alkyl group Chemical group 0.000 abstract 1
230000022131 cell cycle Effects 0.000 abstract 1
230000004663 cell proliferation Effects 0.000 abstract 1
229940127089 cytotoxic agent Drugs 0.000 abstract 1
239000002254 cytotoxic agent Substances 0.000 abstract 1
238000010511 deprotection reaction Methods 0.000 abstract 1
238000003683 electrophilic halogenation reaction Methods 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000000468 ketone group Chemical group 0.000 abstract 1
230000031864 metaphase Effects 0.000 abstract 1
230000003647 oxidation Effects 0.000 abstract 1
238000007254 oxidation reaction Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Oncology (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Plural Heterocyclic Compounds (AREA)

DK315281A 1980-07-15 1981-07-15 Fremgangsmaade til fremstilling af pyrimidin-2-oner eller salte deraf DK315281A (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB8023063		1980-07-15

Publications (1)

Publication Number	Publication Date
DK315281A true DK315281A (da)	1982-01-16

Family

ID=10514771

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK315281A DK315281A (da)	1980-07-15	1981-07-15	Fremgangsmaade til fremstilling af pyrimidin-2-oner eller salte deraf

Country Status (12)

Country	Link
US (1)	US4636509A (da)
EP (1)	EP0044704B1 (da)
JP (1)	JPS5740471A (da)
AT (1)	ATE19627T1 (da)
AU (1)	AU7300381A (da)
CA (1)	CA1160226A (da)
DE (1)	DE3174554D1 (da)
DK (1)	DK315281A (da)
ES (2)	ES503984A0 (da)
NO (1)	NO812431L (da)
NZ (1)	NZ197714A (da)
ZA (1)	ZA814845B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0087326B1 (en) *	1982-02-24	1987-05-13	Nycomed As	Substituted pyrimidin-2-ones and the salts thereof
GB2135992B (en) *	1983-01-11	1986-09-24	Nyegaard & Co As	Substituted pyrimidines and processes for their preparation
GB8420610D0 (en) *	1984-08-14	1984-09-19	Glaxo Group Ltd	Chemical compounds
US4849426A (en) *	1987-05-15	1989-07-18	Pearlman Dale L	Method for treating actinic keratosis with cytotoxic agents
US4853388A (en) *	1987-05-15	1989-08-01	Pearlman Dale L	Method for treating psoriasis with cytotoxic agents
US4820711A (en) *	1987-05-15	1989-04-11	Pearlman Dale L	Method for treating actinic keratosis with cytotoxic agents
US4855466A (en) *	1987-12-28	1989-08-08	E. R. Squibb & Sons, Inc.	Purinyl cyclobutanes
CN1087725C (zh) *	1994-03-25	2002-07-17	同位素技术有限公司	用氘代方法增强药物效果
US6334997B1 (en)	1994-03-25	2002-01-01	Isotechnika, Inc.	Method of using deuterated calcium channel blockers
NZ552372A (en)	2004-06-04	2009-11-27	Astellas Pharma Inc	Propane-1,3-dione derivative or its salt
SI1864976T1 (sl) *	2005-03-31	2012-12-31	Astellas Pharma Inc.	Propan-1,3-dionski derivat ali njegova sol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1561290A (en) *	1975-10-16	1980-02-20	Nyegaard & Co As	Pyrimid - 2 - ones
ES498337A0 (es) *	1980-01-07	1982-06-01	Nyegaard & Co As	Un procedimiento para la preparacion de 5-halo-pirimidin-2- onas
GB2080301B (en) *	1980-07-15	1984-04-18	Glaxo Group Ltd	Substituted pyrimidin-2-ones the salts thereof processes for their preparation and pharmaceutical compositions containing them
GB2080300B (en) *	1980-07-15	1984-04-26	Glaxo Group Ltd	Substituted pyrimidin-2-ones the salts thereof processes for their preparation and pharmaceutical compositions containing them

1981
- 1981-07-14 NZ NZ197714A patent/NZ197714A/en unknown
- 1981-07-14 CA CA000381712A patent/CA1160226A/en not_active Expired
- 1981-07-15 DE DE8181303254T patent/DE3174554D1/de not_active Expired
- 1981-07-15 ES ES503984A patent/ES503984A0/es active Granted
- 1981-07-15 ZA ZA814845A patent/ZA814845B/xx unknown
- 1981-07-15 EP EP81303254A patent/EP0044704B1/en not_active Expired
- 1981-07-15 NO NO812431A patent/NO812431L/no unknown
- 1981-07-15 AU AU73003/81A patent/AU7300381A/en not_active Abandoned
- 1981-07-15 AT AT81303254T patent/ATE19627T1/de not_active IP Right Cessation
- 1981-07-15 JP JP56110634A patent/JPS5740471A/ja active Pending
- 1981-07-15 DK DK315281A patent/DK315281A/da not_active Application Discontinuation
1982
- 1982-06-16 ES ES513177A patent/ES8307758A1/es not_active Expired
1983
- 1983-05-27 US US06/498,723 patent/US4636509A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ATE19627T1 (de)	1986-05-15
EP0044704A1 (en)	1982-01-27
ES8301473A1 (es)	1982-12-01
JPS5740471A (en)	1982-03-06
US4636509A (en)	1987-01-13
ES503984A0 (es)	1982-12-01
ES513177A0 (es)	1983-07-01
NO812431L (no)	1982-01-18
ES8307758A1 (es)	1983-07-01
CA1160226A (en)	1984-01-10
EP0044704B1 (en)	1986-05-07
NZ197714A (en)	1984-11-09
DE3174554D1 (en)	1986-06-12
AU7300381A (en)	1982-01-21
ZA814845B (en)	1983-02-23

Legal Events

Date	Code	Title	Description
1987-03-09	ATS	Application withdrawn

Publication	Publication Date	Title
DE122009000040I1 (de)	2009-11-05	Naphthalin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
DK362482A (da)	1983-02-14	Fremgangsmaade til fremstilling af benzimidazolderivater eller terapeutisk acceptable salte deraf
DK315281A (da)	1982-01-16	Fremgangsmaade til fremstilling af pyrimidin-2-oner eller salte deraf
DK92781A (da)	1981-08-30	Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf
ES2000456A6 (es)	1988-03-01	Procedimiento para preparar deirvados de acido eicosatriinoico-5,8,11 y utilizacion de estos en composiciones farmaceuticas y cosmeticas.
ATE4715T1 (de)	1983-10-15	5-halo-pyrimidin-2-one, ihre salze, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
SE7605819L (sv)	1976-11-25	Nya propargyl-2-fenylaminoimidazolin-(2), dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav
SE7709158L (sv)	1978-02-15	Nya substituerade 2-fenylaminoimidazolin-(2)-er, syraadditionssalter derav, lekemedel som innehaller dessa och forfarande for framstellning derav
PT76614B (de)	1986-01-17	Thiomethylpyridin-derivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
SE7902302L (sv)	1979-09-16	Nya n-fenylalaninderivat, deras framstellning och deras anvendning som lekemedel
DK315381A (da)	1982-01-16	Fremgangsmaade til fremstilling af substituerede pyrimidin-2-oner eller salte deraf
DK212387A (da)	1987-10-29	Benzhydrylpiperazinderivater eller farmaceutisk acceptable syreadditonssalte og kvaternaere ammoni-umsalte deraf, deres fremstilling og anvendelse
DK0640612T3 (da)	1999-02-15	Hidtil ukendte derivater af 2-(1H)-quinolinon, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdend
NO164098C (no)	1990-08-29	Analogifremgangsmaate for fremstilling av nye racemisk eller optisk aktive, terapeutisk aktive berbanderivater.
NO157214C (no)	1988-02-10	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolcarboxylsyrederivater.